Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections

Bone Marrow Transplant. 1992 Aug;10(2):193-4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bacterial Infections / etiology*
  • Bone Marrow Transplantation* / adverse effects
  • Humans
  • Interleukin-2 / adverse effects*
  • Neoplasms / therapy

Substances

  • Interleukin-2